Published in Int J Tuberc Lung Dis on December 01, 1999
Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev (2006) 3.79
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
Assessment of an optimized mycobacterial interspersed repetitive- unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol (2006) 3.08
Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol (2002) 2.92
Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis. J Clin Microbiol (2002) 2.77
Using GIS technology to identify areas of tuberculosis transmission and incidence. Int J Health Geogr (2004) 2.37
Mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis compared to IS6110-based restriction fragment length polymorphism analysis for investigation of apparently clustered cases of tuberculosis. J Clin Microbiol (2003) 2.33
Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24
Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol (2002) 2.03
Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis (2002) 1.86
High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study. J Clin Microbiol (2004) 1.84
Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol (2001) 1.80
Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Respir Crit Care Med (2010) 1.69
Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol (2002) 1.62
Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.55
Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria. Biomed Res Int (2014) 1.47
Molecular epidemiology of tuberculosis among immigrants in Hamburg, Germany. J Clin Microbiol (2004) 1.46
What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis (2009) 1.45
Occupational risk of tuberculosis transmission in a low incidence area. Respir Res (2005) 1.32
Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J Clin Microbiol (2011) 1.30
Increased transmission of Mycobacterium tuberculosis Beijing genotype strains associated with resistance to streptomycin: a population-based study. PLoS One (2012) 1.12
Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis (2010) 1.05
Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect Dis (2010) 1.00
Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras. BMC Microbiol (2010) 0.99
Clustering of tuberculosis cases based on variable-number tandem-repeat typing in relation to the population structure of Mycobacterium tuberculosis in the Netherlands. J Clin Microbiol (2013) 0.98
Clustered tuberculosis in a low-burden country: nationwide genotyping through 15 years. J Clin Microbiol (2012) 0.97
Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. J Clin Microbiol (2003) 0.96
Clustering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors. Clin Dev Immunol (2010) 0.95
Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection. Int J Tuberc Lung Dis (2010) 0.95
Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland. J Clin Microbiol (2010) 0.94
Transmission classification model to determine place and time of infection of tuberculosis cases in an urban area. J Clin Microbiol (2008) 0.90
DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda. BMC Infect Dis (2009) 0.90
The transmission of tuberculosis in the light of new molecular biological approaches. Occup Environ Med (2004) 0.90
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007. Emerg Infect Dis (2013) 0.89
Effect of study design and setting on tuberculosis clustering estimates using Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeats (MIRU-VNTR): a systematic review. BMJ Open (2015) 0.88
A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control. BMC Infect Dis (2009) 0.84
[Thoracic manifestation of tuberculosis]. Radiologe (2016) 0.84
Mycobacterium tuberculosis outbreak strain of Danish origin spreading at worrying rates among greenland-born persons in Denmark and Greenland. J Clin Microbiol (2013) 0.83
Local epidemic history as a predictor of tuberculosis incidence in Saskatchewan Aboriginal communities. Int J Tuberc Lung Dis (2011) 0.81
Secondary typing of Mycobacterium tuberculosis isolates with matching IS6110 fingerprints from different geographic regions of the United States. J Clin Microbiol (2001) 0.80
Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru. BMC Infect Dis (2013) 0.80
Tuberculosis microepidemics among dispersed migrants, Birmingham, UK, 2004-2013. Emerg Infect Dis (2015) 0.79
Neighborhood socioeconomic position and tuberculosis transmission: a retrospective cohort study. BMC Infect Dis (2014) 0.78
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country. J Clin Microbiol (2016) 0.77
Re: "Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup". Am J Epidemiol (2014) 0.77
Re: "Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup". Am J Epidemiol (2014) 0.76
A Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data Collection. PLoS One (2015) 0.75
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis (1999) 5.17
Measles in England and Wales--I: An analysis of factors underlying seasonal patterns. Int J Epidemiol (1982) 5.16
Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis (2000) 4.55
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet (2001) 4.33
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect (1997) 3.97
The efficiency of measles and pertussis notification in England and Wales. Int J Epidemiol (1985) 3.64
Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis (1999) 3.25
Predicting the CJD epidemic in humans. Nature (1997) 3.04
Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol (1984) 2.96
On the dynamics of symbiote-dependent cytoplasmic incompatibility in culicine mosquitoes. J Invertebr Pathol (1978) 2.93
Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis (2003) 2.92
Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet (1992) 2.77
Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis (2011) 2.77
Tuberculosis and HIV infection. Lancet (1993) 2.75
Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis (2000) 2.73
The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS (1992) 2.70
Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health (2001) 2.70
Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol (1999) 2.63
Individual versus public priorities in the determination of optimal vaccination policies. Am J Epidemiol (1986) 2.55
Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis (2001) 2.50
Reflections on the elimination of leprosy. Int J Lepr Other Mycobact Dis (1992) 2.43
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis (1998) 2.27
Patterns of initial and acquired antituberculosis drug resistance in Karonga District, Malawi. Lancet (1995) 2.24
Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24
Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis (2005) 2.23
Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Bull World Health Organ (1998) 2.23
Vectors and vertical transmission: an epidemiologic perspective. Ann N Y Acad Sci (1975) 2.20
Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands. J Clin Microbiol (2000) 2.20
BCG vaccination against tuberculosis and leprosy. Br Med Bull (1988) 2.19
Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the population. Int J Epidemiol (1982) 2.16
Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci (1993) 2.08
High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis (2009) 2.06
Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol (2000) 2.05
The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet (1982) 2.05
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04
An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis (2006) 2.03
Predicting the global spread of new infectious agents. Am J Epidemiol (1986) 2.03
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet (1993) 2.01
Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax (2005) 1.98
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med (1999) 1.97
The development of the HIV epidemic in Karonga District, Malawi. AIDS (2001) 1.97
Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis (2006) 1.91
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91
Attention to gender issues in tuberculosis control. Int J Tuberc Lung Dis (2001) 1.86
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Establishment and development of the National Tuberculosis Control Programme in Vietnam. Int J Tuberc Lung Dis (2005) 1.84
Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis (1999) 1.81
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev (1982) 1.78
Effects of cytokines on the liver. Hepatology (1991) 1.76
Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis (2001) 1.73
Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage. Thorax (1989) 1.72
Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect (2008) 1.71
Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis (2013) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65
Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule. Bull World Health Organ (2008) 1.65
Cleavage of zearalenone-glycoside, a "masked" mycotoxin, during digestion in swine. Zentralbl Veterinarmed B (1990) 1.64
Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J (2009) 1.63
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS (2001) 1.63
Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis (2008) 1.63
Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol (2002) 1.62
Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62
Exogenous reinfection in tuberculosis. N Engl J Med (1999) 1.60
Type 1 reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr Rev (1994) 1.58
Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis (2011) 1.57
HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiol Infect (2007) 1.57
Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol (1992) 1.56
Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. Int J Tuberc Lung Dis (2004) 1.55
Tuberculous pericarditis confirmed by DNA amplification. Lancet (1991) 1.54
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52
Leprosy by the year 2000--what is being eliminated? Lepr Rev (1997) 1.52
Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis (2001) 1.52
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol (1999) 1.49
Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry (2004) 1.48
Protective efficacy of BCG against leprosy in Northern Malawi. Lancet (1986) 1.48
[Hospital infections and risk factors in the intensive care units of 16 Dutch hospitals, results of surveillance of quality assurance indicators]. Ned Tijdschr Geneeskd (2001) 1.48
Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. Int J Tuberc Lung Dis (2001) 1.48
The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis (2009) 1.48
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47
Diagnostic delay in psychogenic nonepileptic seizures. Neurology (2002) 1.45
Defining and assessing the maximum number of visits patients should make to a health facility to obtain a diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2003) 1.44
Asymmetric repair of bacteriophage T7 heteroduplex DNA. Mol Gen Genet (1981) 1.44
Targeting of an abundant cytosolic form of the protein import receptor at Toc159 to the outer chloroplast membrane. J Cell Biol (2001) 1.44
Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy. Int J Tuberc Lung Dis (2006) 1.43